Real-time quantitative PCR results indicated that MEG3 was robustly expressed in bone marrow CD34+ cells, significantly downregulated in all AML samples, particularly in the WT1- or TET2-mutant AML subtypes (Figures 1a and b). The gene discussed is TET2; the disease is acute myeloid leukemia.